HERPES ZOSTER (HZ)
Clinical trials for HERPES ZOSTER (HZ) explained in plain language.
Never miss a new study
Get alerted when new HERPES ZOSTER (HZ) trials appear
Sign up with your email to follow new studies for HERPES ZOSTER (HZ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shingles vaccine trial aims to protect millions over 40
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new shingles vaccine in 645 healthy adults aged 40 and older. Researchers will give two doses and check for side effects and immune response. The goal is to see if the vaccine is safe and helps the body fight the virus that causes shingles.
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:02 UTC
-
Could an extra shingles shot protect kidney transplant patients?
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at how well the shingles vaccine (Shingrix) works and how safe it is in adults with kidney failure who are waiting for a kidney transplant. Some participants will get an extra dose of the vaccine after their transplant to see if it improves their immune protectio…
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC
-
Shingles may trigger brain decline, new study investigates
Knowledge-focused Recruiting nowThis study looks at whether having shingles (herpes zoster) raises the risk of vascular dementia, a type of memory loss caused by poor blood flow to the brain. Researchers will compare 375 adults—some with shingles and some without—by analyzing tiny particles in their blood over …
Matched conditions: HERPES ZOSTER (HZ)
Sponsor: Center for Clinical Studies, Texas • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC